Literature DB >> 25710887

A novel role of angiopoietin-like-3 associated with podocyte injury.

Junchao Liu1, Xia Gao1, Yihui Zhai1, Qian Shen1, Li Sun1, Chun Feng2, Jia Rao1, Haimei Liu1, Xiliang Zha3, Muyi Guo4, Duan Ma5, Zhigang Zhang4, Ruixi Li6, Hong Xu1.   

Abstract

BACKGROUND: Angiopoietin-like-3 (ANGPTL3) expression is increased in glomerular podocytes of nephrotic syndrome. We hypothesize whether ANGPTL3 plays an important role in podocyte injury and promoting proteinuria.
METHODS: Angptl3(+/+) and Angptl3(-/-) female mice on B6;129S5 gene background were injected with adriamycin by tail vein at the dose of 25 mg/Kg to produce nephropathy. Proteinuira was measured and podocytes ultrastructure was observed by electron microscopy. The interaction between ANGPTL3 and intergrin β3 was analyzed by CO-IP and confocal immunofluorescence. The relative gene and protein expression were analyzed by RT-PCR and western blot.
RESULTS: The deletion of ANGPTL3 tremendously attenuates proteinuria (more than a fivefold decrease in albuminuria) and protects podocytes from injury in a mouse model of adriamycin-induced nephropathy. We further demonstrate that ANGPTL3 interacts with and activates podocyte-expressed integrin β3 and regulate expression of α-actinin-4, which may result in the cytoskeletal rearrangement of podocytes. Additionally, we identify the activation of the ANGPTL3-integrin β3 signaling pathway in patients with nephrotic syndrome.
CONCLUSION: ANGPTL3 might play a crucial role in podocyte injury. Either decreasing ANGPTL3 expression or interfering with the ANGPTL3-integrin β3 interaction might be benefit for podocyte protection and decrease proteinuira.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25710887     DOI: 10.1038/pr.2015.38

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

Review 1.  Podocyte-actin dynamics in health and disease.

Authors:  Luca Perico; Sara Conti; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

Review 2.  Angiopoietin-like 3 in lipoprotein metabolism.

Authors:  Sander Kersten
Journal:  Nat Rev Endocrinol       Date:  2017-10-06       Impact factor: 43.330

Review 3.  Beyond the Matrix: The Many Non-ECM Ligands for Integrins.

Authors:  Bryce LaFoya; Jordan A Munroe; Alison Miyamoto; Michael A Detweiler; Jacob J Crow; Tana Gazdik; Allan R Albig
Journal:  Int J Mol Sci       Date:  2018-02-02       Impact factor: 5.923

4.  Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.

Authors:  Rufeng Dai; Haimei Liu; Xinli Han; Junchao Liu; Yihui Zhai; Jia Rao; Qian Shen; Hong Xu
Journal:  BMC Nephrol       Date:  2019-05-24       Impact factor: 2.388

5.  Serum and urine ANGPTL8 expression levels are associated with hyperlipidemia and proteinuria in primary nephrotic syndrome.

Authors:  Yue Li; Qingju Liu; Chengdong Kang; Weijing Cui; Zichuan Xu; Fu Zhong; Xia Gao
Journal:  BMC Nephrol       Date:  2021-04-14       Impact factor: 2.388

6.  ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome.

Authors:  Fu Zhong; Shurao Liu; Yue Li; Xia Gao; Guanyu Li; Ming Liu; Jingzhi Wang; Weijing Cui; Yanhong Suo
Journal:  Lipids Health Dis       Date:  2022-04-10       Impact factor: 3.876

7.  ANGPTL3 is involved in kidney injury in high-fat diet-fed mice by suppressing ACTN4 expression.

Authors:  Guanyu Li; Di Lu; Jingzhi Wang; Shuling Yue; Mei Tan; Ming Liu; Xia Gao
Journal:  Lipids Health Dis       Date:  2022-09-19       Impact factor: 4.315

8.  Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.

Authors:  Qianying Lv; Xinli Han; Jiajia Ni; Qianqian Ma; Rufeng Dai; Jiaojiao Liu; Jialu Liu; Yihui Zhai; Qian Shen; Li Sun; Haimei Liu; Jia Rao; Hong Xu
Journal:  Cell Death Dis       Date:  2022-10-13       Impact factor: 9.685

9.  Comparison of Glomerular Transcriptome Profiles of Adult-Onset Steroid Sensitive Focal Segmental Glomerulosclerosis and Minimal Change Disease.

Authors:  Jun Tong; Jingyuan Xie; Hong Ren; Jian Liu; Weijia Zhang; Chengguo Wei; Jing Xu; Wen Zhang; Xiao Li; Weiming Wang; Danfeng Lv; John Cijiang He; Nan Chen
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

Review 10.  New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.

Authors:  Xin Su; Dao-Quan Peng
Journal:  Lipids Health Dis       Date:  2018-01-15       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.